Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella
Conditions: Rubella; Measles Interventions: Biological: Measles and Rubella vaccine; Biological: Measles, Mumps and Rubella vaccine Sponsors: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz); Oswaldo Cruz Institute Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials